Amy Calamari

Director, Scientific Communications

‍Gilead Sciences

Director, Scientific Communications

‍Gilead Sciences

#Neuroscience #DrugDiscovery #InVitro

#NorthAmerica

Amy Calamari is an Oncology Publication Director in the Scientific Communication group at Gilead Sciences and has over 25 years of experience in the pharmaceutical industry.

Camilla Foged

Professor of Vaccine Design and Delivery

‍University of Copenhagen - University of Copenhagen

Professor of Vaccine Design and Delivery

‍University of Copenhagen - University of Copenhagen

#drugdelivery #vaccines #invitro

#Europe

Camilla is a professor with experience in University Teaching (Pharmaceutics) and research related to delivery of biomacromolecules (Pharmaceutics).

Denis Drygin

Co-Founder, Board of Directors Member

‍Pimera Therapeutics

Co-Founder, Board of Directors Member

‍Pimera Therapeutics

#drugdiscovery #biotechnology #invitro

#NorthAmerica

Denis is a Scientist with 20+ years of experience in biotechnology and pharmaceutical industry. Possesses broad research expertise in the field of drug discovery and development, working with both sma

Pelin Candarlioglu

Chair of Industry Advisory Board

‍EUROoCS

Chair of Industry Advisory Board

‍EUROoCS

#3rs #invitro #celltherapy #organonchip #drugdiscovery

#Europe

I am a preclinical scientist very passionate about adoptive cell therapies, especially developing highly complex in vitro models for CAR-T/TCR efficacy testing.

Priya S. Chockalingam

Vice President, Head of Clinical Bioanalytics & Translational Sciences

‍Beam Therapeutics

Vice President, Head of Clinical Bioanalytics & Translational Sciences

‍Beam Therapeutics

#invitro #cell

#NorthAmerica

I have a PhD in Biochemistry with four years of academic and twenty plus years of pharmaceutical drug discovery & development experience from target id through development, submission, approval, launc